A polymorphism in the angiogenesis inhibitor, endostatin, in multiple myeloma
No abstract is available. To read the body of this article, please view the Full Text online.
To access this article, please choose from the options below
PII: S0145-2126(02)00218-7
© 2002 Elsevier Science Ltd. All rights reserved.
